EE05357B1 - Tablett, mis sisaldab vhemalt kahte eristatavat segmenti, ning selle kasutamine - Google Patents
Tablett, mis sisaldab vhemalt kahte eristatavat segmenti, ning selle kasutamineInfo
- Publication number
- EE05357B1 EE05357B1 EEP200400005A EEP200400005A EE05357B1 EE 05357 B1 EE05357 B1 EE 05357B1 EE P200400005 A EEP200400005 A EE P200400005A EE P200400005 A EEP200400005 A EE P200400005A EE 05357 B1 EE05357 B1 EE 05357B1
- Authority
- EE
- Estonia
- Prior art keywords
- distinct segments
- tablet containing
- tablet
- distinct
- segments
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Oncology (AREA)
- Ophthalmology & Optometry (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30125001P | 2001-06-28 | 2001-06-28 | |
| EP01115807 | 2001-06-28 | ||
| PCT/EP2002/006342 WO2003002098A1 (en) | 2001-06-28 | 2002-06-10 | Tablet comprising cetirizine and pseudoephedrine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EE200400005A EE200400005A (et) | 2004-02-16 |
| EE05357B1 true EE05357B1 (et) | 2010-12-15 |
Family
ID=56290291
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200400005A EE05357B1 (et) | 2001-06-28 | 2002-06-10 | Tablett, mis sisaldab vhemalt kahte eristatavat segmenti, ning selle kasutamine |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP1404304B1 (pt) |
| JP (1) | JP4041460B2 (pt) |
| KR (1) | KR100926410B1 (pt) |
| CN (1) | CN100490809C (pt) |
| AT (1) | ATE432068T1 (pt) |
| AU (1) | AU2002345024B2 (pt) |
| BR (1) | BR0210650A (pt) |
| CA (1) | CA2451519C (pt) |
| CZ (1) | CZ20033454A3 (pt) |
| DK (1) | DK1404304T3 (pt) |
| EE (1) | EE05357B1 (pt) |
| ES (1) | ES2324769T3 (pt) |
| HU (1) | HU229803B1 (pt) |
| MX (1) | MXPA03010430A (pt) |
| NZ (1) | NZ530289A (pt) |
| PL (1) | PL206069B1 (pt) |
| PT (1) | PT1404304E (pt) |
| RO (1) | RO122476B1 (pt) |
| RU (1) | RU2286784C2 (pt) |
| SI (1) | SI1404304T1 (pt) |
| SK (1) | SK287645B6 (pt) |
| WO (1) | WO2003002098A1 (pt) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20090029314A (ko) * | 2001-06-28 | 2009-03-20 | 유씨비 파쉼 소시에떼아노님 | 세티리진 및 슈도에페드린을 포함하는 정제 |
| KR100698400B1 (ko) | 2004-04-14 | 2007-03-23 | 이은주 | 탈모증 및 전립선비대증 치료를 위한 약제학적 조성물 |
| US20100172984A1 (en) * | 2006-06-06 | 2010-07-08 | Bijay Kumar Padhi | tablet dosage form comprising cetirizine and pseudoephedrine |
| RU2446796C2 (ru) | 2006-12-26 | 2012-04-10 | Фармасайкликс, Инк. | Способ использования ингибиторов гистондеацетилазы и мониторинга биомаркеров в комбинированной терапии |
| US8439033B2 (en) | 2007-10-09 | 2013-05-14 | Microdose Therapeutx, Inc. | Inhalation device |
| EP3431128A1 (en) | 2010-01-05 | 2019-01-23 | MicroDose Therapeutx, Inc. | Inhalation device and method |
| KR101193495B1 (ko) * | 2010-02-01 | 2012-10-23 | 한미사이언스 주식회사 | 슈도에페드린 및 레보세티리진을 포함하는 경구용 복합 조성물 |
| CN103002896A (zh) * | 2010-06-16 | 2013-03-27 | 布鲁斯·钱德勒·梅 | 左西替利嗪和孟鲁司特在治疗流感、普通感冒和炎症中的用途 |
| CN102302497A (zh) * | 2011-05-18 | 2012-01-04 | 天圣制药集团股份有限公司 | 一种治疗过敏性鼻炎的制剂及其制备方法 |
| KR20130009553A (ko) | 2011-07-15 | 2013-01-23 | 한미약품 주식회사 | 몬테루카스트 또는 이의 약학적으로 허용가능한 염 및 레보세티리진 또는 이의 약학적으로 허용가능한 염을 함유하는 캡슐 제제 |
| MX365393B (es) | 2011-09-13 | 2019-05-31 | Pharmacyclics Llc | Formulaciones de inhibidor de histona deacetilasa en combinación con bendamustina y usos de las mismas. |
| KR101372324B1 (ko) * | 2012-02-09 | 2014-03-13 | 동국대학교 경주캠퍼스 산학협력단 | 알러지성 비염 치료를 위한 한방 치료제 및 슈도에페드린을 함유한 복합서방형의 약제학적 조성물 |
| CA2901421A1 (en) | 2013-03-13 | 2014-10-09 | Bruce Chandler May | Use of levocetirizine and montelukast in the treatment of autoimmune disorders |
| RU2015134422A (ru) | 2013-03-13 | 2017-04-18 | Инфламматори Респонс Ресёрч, Инк. | Применение левоцитиризина и монтелукаста при лечении васкулита |
| CN105517631A (zh) | 2013-03-13 | 2016-04-20 | 炎症反应研究公司 | 左西替利嗪和孟鲁司特在治疗创伤性损伤中的用途 |
| JP2017526728A (ja) | 2014-09-15 | 2017-09-14 | インフラマトリー・レスポンス・リサーチ・インコーポレイテッド | 炎症介在性状態の治療におけるレボセチリジン及びモンテルカスト |
| WO2016140630A1 (en) | 2015-03-05 | 2016-09-09 | PHARMACTIVE ILAÇ SANAYI VE TlCARET A. Ş. | An effervescent composition comprising levocetirizine and pseudoephedrine |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0811374A1 (en) * | 1996-05-29 | 1997-12-10 | Pfizer Inc. | Combination dosage form comprising cetirizine and pseudoephedrine |
| BE1011045A3 (fr) * | 1997-03-14 | 1999-04-06 | Ucb Sa | Compositions pharmaceutiques pour la liberation controlee de substances actives. |
| US6267986B1 (en) * | 1999-09-24 | 2001-07-31 | Ranbaxy Laboratories Limited | Process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine |
-
2002
- 2002-06-10 PT PT02743173T patent/PT1404304E/pt unknown
- 2002-06-10 SK SK1550-2003A patent/SK287645B6/sk not_active IP Right Cessation
- 2002-06-10 BR BR0210650-7A patent/BR0210650A/pt not_active Application Discontinuation
- 2002-06-10 DK DK02743173T patent/DK1404304T3/da active
- 2002-06-10 NZ NZ530289A patent/NZ530289A/en unknown
- 2002-06-10 AU AU2002345024A patent/AU2002345024B2/en not_active Ceased
- 2002-06-10 RU RU2004101231/15A patent/RU2286784C2/ru active
- 2002-06-10 CA CA002451519A patent/CA2451519C/en not_active Expired - Lifetime
- 2002-06-10 RO ROA200301062A patent/RO122476B1/ro unknown
- 2002-06-10 EP EP02743173A patent/EP1404304B1/en not_active Expired - Lifetime
- 2002-06-10 CZ CZ20033454A patent/CZ20033454A3/cs unknown
- 2002-06-10 WO PCT/EP2002/006342 patent/WO2003002098A1/en active Application Filing
- 2002-06-10 CN CNB02812975XA patent/CN100490809C/zh not_active Expired - Lifetime
- 2002-06-10 MX MXPA03010430A patent/MXPA03010430A/es active IP Right Grant
- 2002-06-10 ES ES02743173T patent/ES2324769T3/es not_active Expired - Lifetime
- 2002-06-10 SI SI200230844T patent/SI1404304T1/sl unknown
- 2002-06-10 AT AT02743173T patent/ATE432068T1/de active
- 2002-06-10 HU HU0400386A patent/HU229803B1/hu unknown
- 2002-06-10 KR KR1020037017054A patent/KR100926410B1/ko active IP Right Grant
- 2002-06-10 PL PL366800A patent/PL206069B1/pl unknown
- 2002-06-10 EE EEP200400005A patent/EE05357B1/xx unknown
- 2002-06-10 JP JP2003508337A patent/JP4041460B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| RU2286784C2 (ru) | 2006-11-10 |
| SK15502003A3 (sk) | 2004-05-04 |
| PT1404304E (pt) | 2009-06-26 |
| EP1404304B1 (en) | 2009-05-27 |
| SK287645B6 (sk) | 2011-05-06 |
| CA2451519A1 (en) | 2003-01-09 |
| CA2451519C (en) | 2007-11-06 |
| MXPA03010430A (es) | 2004-12-06 |
| DK1404304T3 (da) | 2009-07-13 |
| SI1404304T1 (sl) | 2009-10-31 |
| ES2324769T3 (es) | 2009-08-14 |
| JP2004536829A (ja) | 2004-12-09 |
| AU2002345024B2 (en) | 2006-09-07 |
| BR0210650A (pt) | 2004-10-05 |
| PL206069B1 (pl) | 2010-06-30 |
| KR20040007756A (ko) | 2004-01-24 |
| EP1404304A1 (en) | 2004-04-07 |
| HU229803B1 (en) | 2014-07-28 |
| CZ20033454A3 (cs) | 2004-08-18 |
| NZ530289A (en) | 2004-11-26 |
| JP4041460B2 (ja) | 2008-01-30 |
| HUP0400386A2 (hu) | 2004-08-30 |
| CN1520285A (zh) | 2004-08-11 |
| RO122476B1 (ro) | 2009-07-30 |
| KR100926410B1 (ko) | 2009-11-12 |
| CN100490809C (zh) | 2009-05-27 |
| HUP0400386A3 (en) | 2006-02-28 |
| WO2003002098A1 (en) | 2003-01-09 |
| RU2004101231A (ru) | 2005-04-20 |
| PL366800A1 (en) | 2005-02-07 |
| EE200400005A (et) | 2004-02-16 |
| ATE432068T1 (de) | 2009-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE200400005A (et) | Tablett, mis sisaldab vähemalt kahte eristatavat segmenti ning selle kasutamine | |
| NO20034056D0 (no) | Proliferative sykdommer | |
| HK1092467A1 (en) | N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses n- | |
| SE0301653D0 (sv) | Novel compounds | |
| ATE433973T1 (de) | Azolylaminoazine als inhibitoren von proteinkinasen | |
| MA27998A1 (fr) | Nouvelle formulation | |
| GB0111186D0 (en) | Novel compounds | |
| CY1108932T1 (el) | Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων | |
| NO20035025L (no) | Anvendelse av osteopontin for behandling og/eller for a hindre nevrologiske sykdommer, samt farmasoytisk sammensetning omfattende osteopontin eller en antagonist med osteopontinaktivitet. | |
| CY1109238T1 (el) | Δισκιο περιεχον σετιριζινη και ψευδοεφεδρινη | |
| WO2003088748A8 (en) | Use of heme oxygenase-1 and products of heme degradation | |
| AU2001266152A1 (en) | Novel substituted nitrocatechols, their use in the treatment of some central andperipheral nervous system disorders and pharmaceutical compositions containing them | |
| MY135829A (en) | Analeptic and drug combinations | |
| EA200300727A1 (ru) | Производные 2h-1-бензопирана, способы их получения и их фармацевтические композиции | |
| MXPA03007653A (es) | Uso de lp82 para tratar trastornos hematopoyeticos. | |
| CY1110368T1 (el) | Συνεργιστικος συνδυασμος ο οποιος περιλαμβανει ροφλουμιλαστη και (r,r)-φορμοτερολη | |
| WO2004094465A3 (en) | Synthetic molecules that mimic chemokines | |
| SE0000303D0 (sv) | Novel compounds | |
| WO2006044548A3 (en) | Clopidogrel compositions | |
| DE60322577D1 (de) | Tablette enthaltend efletirizin und pseudoephedrin | |
| AU2002354698A1 (en) | Use of xaa-pro peptidases for the treatment of substance p-related disorders | |
| EA200400296A1 (ru) | Применение ингибиторов il-18 при расстройствах в виде гиперчувствительности | |
| EA200500538A1 (ru) | Фармацевтическое средство для эндоназального применения при лечении болезней и нарушений нервной системы | |
| ATE390144T1 (de) | Behandlung von fibrosen | |
| EA200600183A1 (ru) | Сочетание ингибитора обратного захвата серотонина и агомелатина |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HB1A | Correction of owner name or address | ||
| KB4A | Valid patent at the end of a year |
Effective date: 20101231 |
|
| HC1A | Change of owner name |